About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
Beth Israel Deaconess Medical Center
›
Center for Virology and Vaccine Research
›
Top Articles
Center for Virology and Vaccine Research
Beth Israel Deaconess Medical Center
538
Articles
26K
Citations
10
avg. Impact Factor
80
h-index
Most Cited Articles of Center for Virology and Vaccine Research in 2022
Title
Journal
Year
Citations
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
JAMA - Journal of the American Medical Association
2022
16
Advances and gaps in SARS-CoV-2 infection models.
PLoS Pathogens
2022
13
Reduced Pathogenicity of the SARS-CoV-2 Omicron Variant in Hamsters.
Med
2022
13
Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant.
Science Translational Medicine
2022
12
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions.
Science Translational Medicine
2022
11
Structural and functional impact by SARS-CoV-2 Omicron spike mutations.
Cell Reports
2022
8
Defining the risk of SARS-CoV-2 variants on immune protection.
Nature
2022
7
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
Lancet, The
2022
7
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice
Science Translational Medicine
2022
6
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques.
Science Advances
2022
3
COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective.
Open Forum Infectious Diseases
2022
3
Vaccine protection against the SARS-CoV-2 Omicron variant in macaques.
Cell
2022
3
Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice.
Npj Vaccines
2022
2
Serological Markers of SARS-CoV-2 Reinfection.
MBio
2022
1
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques.
Med
2022
1
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques.
Science Translational Medicine
2022
1
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters.
Npj Vaccines
2022
0
Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques.
PLoS Pathogens
2022
0
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.
PLoS Biology
2022
0
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques.
Npj Vaccines
2022
0
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.